MedAdvisor Ltd
MDR
Company Profile
Business description
MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has three reporting segments: ANZ Operations, U.S. Operations and UK Operations. The company derives majority of its revenues from U.S. Operations.
Contact
971 Burke Road
Level 2
CamberwellVIC3124
AUST: +61 390953036
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Ask the analyst: How reliant are Guzman shares on international growth?
A year on from Guzman’s IPO, I catch up with Johannes Faul to explore what is baked into GYG’s valuation.
stocks
Nvidia: Back in business in China; Raising fair value estimate
Nvidia is poised to become more dominant than ever as it is allowed to sell its key H20 GPUs in China.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,890.80 | 74.40 | 0.84% |
CAC 40 | 7,822.00 | 99.91 | 1.29% |
DAX 40 | 24,370.93 | 361.55 | 1.51% |
Dow JONES (US) | 44,393.38 | 138.60 | 0.31% |
FTSE 100 | 8,972.64 | 46.09 | 0.52% |
HKSE | 24,498.95 | 18.81 | -0.08% |
NASDAQ | 20,891.01 | 160.52 | 0.77% |
Nikkei 225 | 39,901.19 | 237.79 | 0.60% |
NZX 50 Index | 12,905.41 | 150.82 | 1.18% |
S&P 500 | 6,289.02 | 25.32 | 0.40% |
S&P/ASX 200 | 8,639.00 | 77.20 | 0.90% |
SSE Composite Index | 3,516.83 | 13.05 | 0.37% |